Galapagos

Ebitda Endring Dato
AstraZeneca USD 3.43B 412M 2023-09
Gilead Sciences USD 2.73B 579M 2023-12
GlaxoSmithKline GBP 3.17B 729M 2023-09
GRIFOLS EUR 334.62M 15.41M 2023-12
Hikma Pharmaceutical USD 504M 154M 2023-06
Incyte USD 226.99M 9.73M 2023-12
Neurocrine Biosciences USD 146.7M 68M 2023-09
Roche Holding CHF 12.35B 1.92B 2023-06
UCB EUR 656M 205M 2023-06
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09



Galapagos - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.